Evaluation of Response to Therapy in Thyroid Carcinoma Patients after Radioactive Iodine Therapy
Radioactive iodine therapy is an important treatment modality for differentiated thyroid carcinoma patients. Radioactive iodine, similar to elementary iodine, is concentrated in the thyroid follicular cells after oral application, and it can damage the remnant or malignant thyroid cells. Unlike many...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Galenos Yayinevi
2016-12-01
|
| Series: | Bagcilar Medical Bulletin |
| Subjects: | |
| Online Access: |
http://behmedicalbulletin.org/archives/archive-detail/article-preview/evaluation-of-response-to-therapy-in-thyroid-carci/23463
|
| _version_ | 1797921832851996672 |
|---|---|
| author | Lebriz Uslu Besli Ilhami Uslu |
| author_facet | Lebriz Uslu Besli Ilhami Uslu |
| author_sort | Lebriz Uslu Besli |
| collection | DOAJ |
| description | Radioactive iodine therapy is an important treatment modality for differentiated thyroid carcinoma patients. Radioactive iodine, similar to elementary iodine, is concentrated in the thyroid follicular cells after oral application, and it can damage the remnant or malignant thyroid cells. Unlike many antineoplastic drugs, radioactive iodine can easily be applied without causing serious side effects.
Radioactive iodine was first used for the treatment of a differentiated thyroid carcinoma patient in 1949. In Turkey, it has been used in many nuclear medicine centers for treatment of both differentiated thyroid carcinoma and hyperthyroid patients since 1954. For evaluation of response to therapy with radioactive iodine, different clinical, biochemical, scintigraphic, and radiological imaging modalities are available. Today, many international guidelines aid the clinicians in the assessment of therapy response after radioiodine application. This review aims to discuss the methods recommended in current guidelines for therapy response assessment in differentiated thyroid carcinoma patients after radioactive iodine therapy. |
| first_indexed | 2024-04-10T14:21:46Z |
| format | Article |
| id | doaj.art-56d01e3102984ea5b8979810cd049ca5 |
| institution | Directory Open Access Journal |
| issn | 2547-9431 |
| language | English |
| last_indexed | 2024-04-10T14:21:46Z |
| publishDate | 2016-12-01 |
| publisher | Galenos Yayinevi |
| record_format | Article |
| series | Bagcilar Medical Bulletin |
| spelling | doaj.art-56d01e3102984ea5b8979810cd049ca52023-02-15T16:09:16ZengGalenos YayineviBagcilar Medical Bulletin2547-94312016-12-0111303210.5350/BMB201601010813049054Evaluation of Response to Therapy in Thyroid Carcinoma Patients after Radioactive Iodine TherapyLebriz Uslu Besli0Ilhami Uslu1 Istanbul Research and Training Hospital, Nuclear Medicine Clinic, Istanbul, Turkey Istanbul University, Cerrahpasa Faculty of Medicine, Department of Nuclear Medicine, Istanbul, Turkey Radioactive iodine therapy is an important treatment modality for differentiated thyroid carcinoma patients. Radioactive iodine, similar to elementary iodine, is concentrated in the thyroid follicular cells after oral application, and it can damage the remnant or malignant thyroid cells. Unlike many antineoplastic drugs, radioactive iodine can easily be applied without causing serious side effects. Radioactive iodine was first used for the treatment of a differentiated thyroid carcinoma patient in 1949. In Turkey, it has been used in many nuclear medicine centers for treatment of both differentiated thyroid carcinoma and hyperthyroid patients since 1954. For evaluation of response to therapy with radioactive iodine, different clinical, biochemical, scintigraphic, and radiological imaging modalities are available. Today, many international guidelines aid the clinicians in the assessment of therapy response after radioiodine application. This review aims to discuss the methods recommended in current guidelines for therapy response assessment in differentiated thyroid carcinoma patients after radioactive iodine therapy. http://behmedicalbulletin.org/archives/archive-detail/article-preview/evaluation-of-response-to-therapy-in-thyroid-carci/23463 thyroid neoplasmsiodine radioisotopestreatment outcome |
| spellingShingle | Lebriz Uslu Besli Ilhami Uslu Evaluation of Response to Therapy in Thyroid Carcinoma Patients after Radioactive Iodine Therapy Bagcilar Medical Bulletin thyroid neoplasms iodine radioisotopes treatment outcome |
| title | Evaluation of Response to Therapy in Thyroid Carcinoma Patients after Radioactive Iodine Therapy |
| title_full | Evaluation of Response to Therapy in Thyroid Carcinoma Patients after Radioactive Iodine Therapy |
| title_fullStr | Evaluation of Response to Therapy in Thyroid Carcinoma Patients after Radioactive Iodine Therapy |
| title_full_unstemmed | Evaluation of Response to Therapy in Thyroid Carcinoma Patients after Radioactive Iodine Therapy |
| title_short | Evaluation of Response to Therapy in Thyroid Carcinoma Patients after Radioactive Iodine Therapy |
| title_sort | evaluation of response to therapy in thyroid carcinoma patients after radioactive iodine therapy |
| topic | thyroid neoplasms iodine radioisotopes treatment outcome |
| url |
http://behmedicalbulletin.org/archives/archive-detail/article-preview/evaluation-of-response-to-therapy-in-thyroid-carci/23463
|
| work_keys_str_mv | AT lebrizuslubesli evaluationofresponsetotherapyinthyroidcarcinomapatientsafterradioactiveiodinetherapy AT ilhamiuslu evaluationofresponsetotherapyinthyroidcarcinomapatientsafterradioactiveiodinetherapy |